Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-{2-[4-(2-methoxylphenyl)piperazino]ethyl}-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes

被引：24

作者：

Ma, Y ^{[1
]}

Lang, LX ^{[1
]}

Kiesewetter, DO ^{[1
]}

Jagoda, E ^{[1
]}

Sassaman, MB ^{[1
]}

Der, M ^{[1
]}

Eckelman, WC ^{[1
]}

机构：

[1] NIH, PET Dept, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA

来源：

JOURNAL OF CHROMATOGRAPHY B | 2001年 / 755卷 / 1-2期

关键词：

5-HT1A antagonists;

D O I：

10.1016/S0378-4347(00)00610-1

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Two 5-HT1A antagonists, t-FCWAY and c-FCWAY, were developed as imaging agents for positron emission tomography (PET). In order to evaluate these compounds, hepatocytes from both human and rat were utilized to produce metabolites and LC-MS-MS was used to identify metabolites. These in vitro metabolism studies indicate that hydrolysis of the amide linkage is the major metabolism pathway for humans, whereas aromatic ring-oxidation is the major metabolism pathway for rat. The rat hepatocyte results correlate well with in vivo rat metabolism studies. Based on the structures of the metabolites, we have developed an extraction procedure to determine the concentration of the parent compound in plasma. Published by Elsevier Science B.V.

引用

页码：47 / 56

页数：10

共 10 条

[1] SILENT 5-HT(1A)-RECEPTOR ANTAGONISTS - UTILITY AS RESEARCH TOOLS AND THERAPEUTIC AGENTS [J].

FLETCHER, A ;

CLIFFE, IA ;

DOURISH, CT .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (12) :441-448

[2]

Gillespie TA, 1996, ACS SYM SER, V619, P315

[3]

LANG L, 1999, J NUCL MED, V40, P37

[4] Development of fluorine-18-labeled 5-HT1A antagonists [J].

Lang, LX ;

Jagoda, E ;

Schmall, B ;

Vuong, BK ;

Adams, HR ;

Nelson, DL ;

Carson, RE ;

Eckelman, WC .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (09) :1576-1586

[5] Biologically stable [18F]-labeled benzylfluoride derivatives [J].

Magata, Y ;

Lang, LX ;

Kiesewetter, DO ;

Jagoda, EM ;

Channing, MA ;

Eckelman, WC .

NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (02) :163-168

[6] Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-C-11]WAY-100635, in monkey and human plasma by HPLC: Comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET [J].

Osman, S ;

Lundkvist, C ;

Pike, VW ;

Halldin, C ;

McCarron, JA ;

Swahn, CG ;

Ginovart, N ;

Luthra, SK ;

Bench, CJ ;

Grasby, PM ;

Wikstrom, H ;

Barf, T ;

Cliffe, IA ;

Fletcher, A ;

Farde, L .

NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (05) :627-634

[7] Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635 -: Explanation of high signal contrast in PET and an aid to biomathematical modelling [J].

Osman, S ;

Lundkvist, C ;

Pike, VW ;

Halldin, C ;

McCarron, JA ;

Swahn, CG ;

Farde, L ;

Ginovart, N ;

Luthra, SK ;

Gunn, RN ;

Bench, CJ ;

Sargent, PA ;

Grasby, PM .

NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (03) :215-223

[8]

Pike VW, 1994, MED CHEM RES, V5, P208

[9]

PIKE VW, 1995, DRUG DEV EVALUATION, P93

[10]

Yan ZM, 2000, DRUG METAB DISPOS, V28, P880

← 1 →